Michael Nassal Selected Research

OspC protein

1/2015	Whole-Chain Tick Saliva Proteins Presented on Hepatitis B Virus Capsid-Like Particles Induce High-Titered Antibodies with Neutralizing Potential.
1/2015	Soluble cysteine-rich tick saliva proteins Salp15 and Iric-1 from E. coli.
6/2006	Hepatitis B virus capsid-like particles can display the complete, dimeric outer surface protein C and stimulate production of protective antibody responses against Borrelia burgdorferi infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael Nassal Research Topics

Disease

17	Infections 01/2021 - 12/2008
8	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 12/2004
5	Persistent Infection 01/2020 - 10/2015
5	Lyme Disease (Disease, Lyme) 01/2015 - 02/2005
4	Hepatitis B 01/2019 - 04/2014
4	Chronic Hepatitis B 12/2015 - 01/2007
2	Liver Diseases (Liver Disease) 10/2016 - 01/2016
1	Neoplasms (Cancer) 01/2016
1	Tick Bites 01/2015
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2013
1	Hepatitis 04/2008

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2019 - 12/2004
7	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 11/2006
4	EpitopesIBA 01/2019 - 02/2005
4	VaccinesIBA 01/2018 - 02/2005
3	RNA (Ribonucleic Acid)IBA 01/2020 - 09/2011
3	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018 - 04/2014
3	Peptides (Polypeptides)IBA 01/2018 - 04/2014
3	AntibodiesIBA 01/2018 - 02/2005
3	Antiviral Agents (Antivirals)IBA 10/2016 - 01/2013
3	1-oleoyl-2-stearoylphosphatidylcholineIBA 01/2015 - 06/2006
3	OspC proteinIBA 01/2015 - 06/2006
2	InterferonsIBA 01/2021 - 01/2007
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 10/2016 - 04/2014
2	OspA proteinIBA 11/2008 - 02/2005
2	Immunoglobulin IsotypesIBA 01/2008 - 02/2005
1	Interferon Type IIBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	Circular DNAIBA 01/2020
1	CytokinesIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2019
1	hepatitis B hyperimmune globulinIBA 01/2019
1	dihydrodibutylstilbestrolIBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 12/2018
1	pgRNAIBA 12/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Viral Matrix ProteinsIBA 01/2018
1	Protons (Proton)IBA 01/2018
1	EnzymesIBA 01/2018
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 10/2016
1	RNA Precursors (Precursor, mRNA)IBA 10/2016
1	GlypicansIBA 01/2016
1	bile acid binding proteinsIBA 12/2015
1	sodium-bile acid cotransporterIBA 12/2015
1	adefovirIBA 01/2015
1	Cysteine (L-Cysteine)FDA Link 01/2015
1	Glycoproteins (Glycoprotein)IBA 01/2015
1	NucleosidesIBA 01/2015
1	NucleotidesIBA 01/2015
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2015
1	Lamivudine (Epivir)FDA Link 01/2015
1	myrcludex-BIBA 04/2014
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 04/2014
1	Bile Acids and Salts (Bile Acids)IBA 04/2014
1	Thioacetamide (Thioacetamid)IBA 01/2013
1	Matrix Metalloproteinase 8 (Neutrophil Collagenase)IBA 01/2013
1	Viral Envelope ProteinsIBA 12/2008
1	AntigensIBA 01/2008
1	Interferon-alpha (Interferon Alfa)IBA 01/2007
1	Lipoproteins (Lipoprotein)IBA 06/2006
1	AcidsIBA 02/2005
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 02/2005
1	Amino Acids FDA Link 12/2004
1	Serine (L-Serine)FDA Link 12/2004
1	Glutamic Acid (Glutamate)FDA Link 12/2004

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2011